Market Cap

OBI Pharma, Inc. Market Capitalization:

TW$7.02 Billion

TWD as of Jan. 1, 2026

US$224.1 Million

business OBI Pharma, Inc. Company Profile

OBI Pharma, Inc. Main Stock Listing

TWSE: 4174

Market Capitalization History of OBI Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of OBI Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 TW$7.02 B -57.63%
Jan. 1, 2025 TW$16.57 B 4.77%
Jan. 1, 2024 TW$15.82 B 1.45%
Jan. 1, 2023 TW$15.59 B -41.18%
Jan. 1, 2022 TW$26.51 B 3.49%
Jan. 1, 2021 TW$25.61 B -6.91%
Jan. 1, 2020 TW$27.51 B -31.05%
Jan. 1, 2019 TW$39.91 B -2.70%
Jan. 1, 2018 TW$41.02 B -36.21%
Jan. 1, 2017 TW$64.29 B -18.99%
Jan. 1, 2015 TW$79.37 B 68.86%
Jan. 1, 2014 TW$47.00 B 76.44%
Jan. 1, 2013 TW$26.64 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

OBI Pharma, Inc. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

OBI Pharma, Inc. has the following listings and related stock indices.


Stock: TWSE: 4174

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.